SY

Steven Yecies

Managing Partner Kain Capital

San Francisco Bay Area

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Managing Partner

    2022

    Kain Capital invests exclusively in healthcare services and healthcare IT companies. Kain partners with entrepreneurs and physicians to build transformative healthcare companies to improve how healthcare is delivered to patients. Kain has not utilized debt in its seven platform investments and focuses on creating significant growth with its partners. Kain focuses on technology enablement of its portfolio companies to both enhance existing operations and enable transformation to risk based business models.

  • Non-Executive Chairman of the Board

    2022

    PERA Holdings is a centralized national, operating company that acquires and operates outstanding regional hospice and palliative care companies.

2022

  • Board Member

    2022

    Leading provider of primary care services in the Arizona market. Offers high quality affordable care in a manner that is highly convenient to patients with high traffic retail locations that are open seven days a week. MDN also provides care through video visits and provider in home visits.

2013 - 2022

  • Consultant

    2018 - 2022

    Continued to serve as OrbiMed representative on Board of Directors where I played a primary role in originating and managing the investment.

  • Venture Partner

    2013 - 2018

    Served as a Venture Partner at OrbiMed responsible for our health care IT and health care services investments. I work with OrbiMed colleagues in sourcing, executing, and managing private investments in these sub-sectors. To date OrbiMed has made several health care IT and services investments across its global private funds. OrbiMed Advisors LLC is a leading investment firm dedicated exclusively to the healthcare sector. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies, in a variety of sub-sectors including biopharmaceuticals, medical devices and health IT. OrbiMed’s team of professionals manages a series of private equity funds, public equity funds, royalty funds and other investment vehicles. The firm operates out of five offices – New York, Tel Aviv, San Francisco, Shanghai and Mumbai. http://www.orbimed.com

2014 - 2022

  • Board Member

    2014 - 2022

    Served as Board Member for TigerConnect (formerlyTigerText) from January 2014 through February 2022. During this tenure the company's revenues increased by 20X and post money valuation by more than 10X. TigerConnect is healthcare's most advanced connected clinical communication platform. The company is the market leader among US hospitals and integrated health systems for providing integrated enterprise communications and automated work flow.

2015 - 2022

  • Board Member

    2015 - 2022

    Sikka is a leading marketplace for over 25,000 dental and veterinarian practices and hundreds of industry suppliers of products and services. Sikka integrates to almost all electronic clinical records and financial management systems of the practices. The company also has a robust information services business.

2020 - 2021

  • Chief Executive Officer

    2020 - 2021

    Javelin Oncology introduces a new capability to precision immune medicine. This enables us to predict patient responses to treatment, significantly reducing the time and resources required to launch new immunotherapies. We apply our platform both to create novel therapies in our own labs and as a service to other life sciences companies to help them advance their discovery and development of immuno-oncology therapies. Led licensing of lead assets to leading European Biotech company before exiting company.

2013 - 2018

  • Board Member

    2013 - 2018

    Practice Fusion is the leading provider of cloud based electronic medical records and is the fourth largest EMR provider in the United States. Practice Fusion was sold to AllScripts (MDRX) in January, 2018

2016 - 2018

  • Board Member

    2016 - 2018

    Augmedix is a leading provider of scribing services and automated work flow solutions to providers at many of the leading integrated health systems. Augmedix has offices and partners in the United Sates, Bangladesh, India, Sri Lanka and the Dominican Republic.

  • Founder and CEO

    2010 - 2013

    Chronic Health Capital is a private equity firm that executed investments in health care services and health care information technology companies.